{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:52:15Z","timestamp":1790880735659,"version":"4.1.0"},"reference-count":26,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T00:00:00Z","timestamp":1665273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>This study aimed to compare adalimumab originator vs. biosimilar in HS patients, and to evaluate the effect of a switch to a biosimilar, or a switch back to the originator, in terms of treatment ineffectiveness. Patients with a diagnosis of HS were enrolled from 14 Italian sites. Treatment ineffectiveness was measured using Hurley score. The major analyses were 1) comparison between the two treatment groups (non-switcher analysis), and 2) the cross-over trend of Hurley score between treatment switchers (switcher analysis). Cox and Poisson regression models were used to compare the treatment ineffectiveness between groups. A total of 326 patients were divided into four groups: 171 (52.5%) taking originator; 61 (18.7%) patients taking biosimilar; 66 (20.2%) switchers; 28 (8.6%) switchers from originator to biosimilar and switched. A greater loss of efficacy was observed in the group allocated to the biosimilar than the originator group. The switcher analysis showed an effectiveness loss in the biosimilar compared to the originator. These results seem to indicate that a switch from one drug to the other may lead to a greater risk of inefficacy. A return to the previous treatment also does not ensure efficaciousness.<\/jats:p>","DOI":"10.3390\/biomedicines10102522","type":"journal-article","created":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T20:49:31Z","timestamp":1665348571000},"page":"2522","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Adalimumab Originator vs. Biosimilar in Hidradenitis Suppurativa: A Multicentric Retrospective Study"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4381-6718","authenticated-orcid":false,"given":"Martina","family":"Burlando","sequence":"first","affiliation":[{"name":"Division of Dermatology, Department of Health and Science (DissaL), Policlinico San Martino Hospital, IRCCS, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Fabbrocini","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Dermatology, University Hospital Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8401-5730","authenticated-orcid":false,"given":"Claudio","family":"Marasca","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine and Surgery, Section of Dermatology, University Hospital Federico II, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Dapavo","sequence":"additional","affiliation":[{"name":"Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic, University of Turin, 10124 Turin, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Chiricozzi","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, A. Gemelli University Polyclinic, IRCCS and Foundation, Sacred Heart Catholic University, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalma","family":"Malvaso","sequence":"additional","affiliation":[{"name":"Institute of Dermatology, A. Gemelli University Polyclinic, IRCCS and Foundation, Sacred Heart Catholic University, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Dini","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Pisa, 56126 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3740-0839","authenticated-orcid":false,"given":"Anna","family":"Campanati","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Offidani","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Clinical and Molecular Sciences, Polytechnic Marche University, 60126 Ancona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9504-5882","authenticated-orcid":false,"given":"Annunziata","family":"Dattola","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0456-9582","authenticated-orcid":false,"given":"Raffaele Dante Caposiena","family":"Caro","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8697-6896","authenticated-orcid":false,"given":"Luca","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Venturini","sequence":"additional","affiliation":[{"name":"Department of Dermatology, ASST Spedali Civili di Brescia, 25126 Brescia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1777-9001","authenticated-orcid":false,"given":"Paolo","family":"Gisondi","sequence":"additional","affiliation":[{"name":"Section of Dermatology and Venereology, Department of Medicine, University of Verona, 37129 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3918-8779","authenticated-orcid":false,"given":"Claudio","family":"Guarneri","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Malara","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Grande Ospedale Metropolitano \u201cBianchi Melacrino Morelli\u201d, 89124 Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Trifir\u00f2","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Grande Ospedale Metropolitano \u201cBianchi Melacrino Morelli\u201d, 89124 Reggio Calabria, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorigio","family":"Malagoli","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Azienda Ospedaliera San Donato Milanese, 20097 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7249-2556","authenticated-orcid":false,"given":"Maria Concetta","family":"Fargnoli","sequence":"additional","affiliation":[{"name":"Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L\u2019Aquila, 67100 L\u2019Aquila, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1091-4733","authenticated-orcid":false,"given":"Stefano","family":"Piaserico","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Medicine, University of Padova, 35122 Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6263-3864","authenticated-orcid":false,"given":"Luca","family":"Carmisciano","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Health and Science (DissaL), Policlinico San Martino Hospital, IRCCS, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Castelli","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Health and Science (DissaL), Policlinico San Martino Hospital, IRCCS, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Parodi","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Health and Science (DissaL), Policlinico San Martino Hospital, IRCCS, 16132 Genova, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis Suppurativa: Advances in Diagnosis and Treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jamadermatol.2016.0185","article-title":"Hidradenitis Suppurativa","volume":"152","author":"Alikhan","year":"2016","journal-title":"JAMA Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br. J. Dermatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"248","DOI":"10.4103\/ijdvl.IJDVL_69_18","article-title":"Hidradenitis Suppurativa: A Systematic Review and Meta-analysis of Therapeutic Interventions","volume":"85","author":"Tchero","year":"2019","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_5","first-page":"18","article-title":"Multidisciplinary approach for hidradenitis suppurativa patients","volume":"153","author":"Veraldi","year":"2018","journal-title":"G Ital. Dermatol. Venereol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","article-title":"Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa","volume":"17","author":"Gulliver","year":"2016","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijwd.2020.02.006","article-title":"Integrated multidisciplinary approach to hidradenitis suppurativa in clinical practice","volume":"6","author":"Touhouche","year":"2020","journal-title":"Int. J. Womens Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_9","first-page":"291","article-title":"Adalimumab (Humira) for Hidradenitis Suppurativa","volume":"14","author":"Gupta","year":"2016","journal-title":"Skinmed"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1001\/jama.2019.16275","article-title":"Adalimumab and the Challenges for Biosimilars","volume":"322","author":"Gellad","year":"2019","journal-title":"JAMA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4155\/ppa-2016-0002","article-title":"Humira: The impending patent battles over adalimumab biosimilars","volume":"5","author":"Norman","year":"2016","journal-title":"Pharm. Pat. Anal."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e14387","DOI":"10.1111\/dth.14387","article-title":"Clinical experience with adalimumab biosimilar imraldi in hidradenitis suppurativa","volume":"33","author":"Ricceri","year":"2020","journal-title":"Dermatol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4103\/ijdvl.IJDVL_232_18","article-title":"Low-dose adalimumab biosimilar (ZRC-3197) in the treatment of hidradenitis suppurativa","volume":"84","author":"Patil","year":"2018","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1080\/13543784.2016.1255724","article-title":"Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE\u00ae-PK) in healthy subjects","volume":"12","author":"Wynne","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_15","first-page":"1031","article-title":"Bioequivalence studies with anti-TNF biosimilars","volume":"10","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Montero-Vilchez, T., Cuenca-Barrales, C., Rodriguez-Tejero, A., Martinez-Lopez, A., Arias-Santiago, S., and Molina-Leyva, A. (2022). Switching from Adalimumab Originator to Biosimilar: Clinical Experience in Patients with Hidradenitis Suppurativa. J. Clin. Med., 11.","DOI":"10.3390\/jcm11041007"},{"key":"ref_17","unstructured":"Roenigk, R.K., and Roenigk, H.H. (1989). Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: Surgical approach. Dermatologic Surgery: Principles and Practice, Marcel Dekker."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/bjd.17769","article-title":"Refining the hidradenitis suppurativa Hurley staging system for mild, moderate and severe disease","volume":"180","author":"Ingram","year":"2019","journal-title":"Br. J. Dermatol."},{"key":"ref_19","unstructured":"R Core Team (2020). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/www.R-project.org\/."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: Nonparametric Preprocessing for Parametric Causal Inference","volume":"42","author":"Ho","year":"2011","journal-title":"J. Stat. Softw."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/14740338.2019.1602117","article-title":"Immunogenicity of infliximab and adalimumab","volume":"18","author":"Murdaca","year":"2019","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Liu, M., Degner, J., Davis, J.W., Idler, K.B., Nader, A., Mostafa, N.M., and Waring, J.F. (2018). Identification of HLA-DRB1 association to adalimumab immunogenicity. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0195325"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40259-018-0307-0","article-title":"SB5, An Adalimumab Biosimilar","volume":"32","author":"Frampton","year":"2018","journal-title":"BioDrugs"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3897\/folmed.62.e39402","article-title":"Drug-neutralizing Antibodies against TNF-alpha blockers as Biomarkers of Therapy Effect Evaluation","volume":"62","author":"Kraev","year":"2020","journal-title":"Folia Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2011.406","article-title":"Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up","volume":"305","author":"Bartelds","year":"2011","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/bjd.17716","article-title":"Inter-rater agreement and reliability of outcome measurement instruments and staging systems used in hidradenitis suppurativa","volume":"181","author":"Thorlacius","year":"2019","journal-title":"Br. J. Dermatol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2522\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:48:53Z","timestamp":1760143733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/10\/2522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,9]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["biomedicines10102522"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10102522","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,9]]}}}